 |
13 Diseases |  |
0 Trials |
|
0 Trials |  |
17 News |  |
- | BIIB023 / Biogen
Trial termination, Trial primary completion date: ATLAS: BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis (clinicaltrials.gov) - Oct 28, 2015
P2, N=188, Terminated, Sponsor: Biogen
Recruiting --> Terminated | Trial primary completion date: Dec 2016 --> Dec 2015; Results from a pre-specified criteria did not demonstrate sufficient efficacy to warrant continuation of the study.
- | BIIB023 / Biogen
Enrollment change, Trial termination, Trial primary completion date: BIIB023 Long-Term Extension Study in Subjects With Lupus Nephritis (clinicaltrials.gov) - Oct 28, 2015
P2, N=87, Terminated, Sponsor: Biogen
Recruiting --> Terminated | Trial primary completion date: Dec 2016 --> Dec 2015; Results from a pre-specified criteria did not demonstrate sufficient efficacy to warrant continuation of the study. N=155 --> 87 | Enrolling by invitation --> Terminated | Trial primary completion date: Feb 2019 --> Dec 2015; Results from pre-specified criteria in study NCT01499355 did not demonstrate sufficient efficacy to warrant continuation of the study
- || BIIB023 / Biogen
Trial primary completion date: ATLAS: BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis (clinicaltrials.gov) - Jul 14, 2015
P2, N=211, Recruiting, Sponsor: Biogen
N=155 --> 87 | Enrolling by invitation --> Terminated | Trial primary completion date: Feb 2019 --> Dec 2015; Results from pre-specified criteria in study NCT01499355 did not demonstrate sufficient efficacy to warrant continuation of the study Trial primary completion date: Sep 2016 --> Dec 2016
- | BIIB023 / Biogen
Trial completion: A Study of the Effect of BIIB023 on Muscle Atrophy in Healthy Male Volunteers (clinicaltrials.gov) - Sep 4, 2014
P1, N=34, Completed, Sponsor: Biogen Idec
Trial primary completion date: Sep 2016 --> Dec 2016 Active, not recruiting --> Completed
- ||| BIIB023 / Biogen
Enrollment change: ATLAS: BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis (clinicaltrials.gov) - Aug 19, 2014
P2, N=211, Recruiting, Sponsor: Biogen Idec
Active, not recruiting --> Completed N=300 --> 211
- BIIB023 / Biogen
Enrollment closed: A Study of the Effect of BIIB023 on Muscle Atrophy in Healthy Male Volunteers (clinicaltrials.gov) - Mar 13, 2014
P1, N=34, Active, not recruiting, Sponsor: Biogen Idec
N=300 --> 211 Recruiting --> Active, not recruiting
- |||| BIIB023 / Biogen
Enrollment open: BIIB023 Long-Term Extension Study in Subjects With Lupus Nephritis (clinicaltrials.gov) - Feb 20, 2014
P2, N=175, Enrolling by invitation, Sponsor: Biogen Idec
Recruiting --> Active, not recruiting Not yet recruiting --> Enrolling by invitation
- | BIIB023 / Biogen
New P1 trial: A Study of the Effect of BIIB023 on Muscle Atrophy in Healthy Male Volunteers (clinicaltrials.gov) - Sep 15, 2013
P1, N=34, Active, not recruiting, Sponsor: Biogen Idec
- ||| BIIB023 / Biogen
Trial initiation date: ATLAS: BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis (clinicaltrials.gov) - Aug 28, 2013
P2, N=300, Recruiting, Sponsor: Biogen Idec
Not yet recruiting --> Enrolling by invitation Initiation date: Jan 2012 --> Jul 2012
- ||||| BIIB023 / Biogen
New P2 trial: BIIB023 Long-Term Extension Study in Subjects With Lupus Nephritis (clinicaltrials.gov) - Aug 27, 2013
P2, N=175, Enrolling by invitation, Sponsor: Biogen Idec
- | BIIB023 / Biogen
Trial completion: Phase 1 Study to Evaluate the PK, Safety, Tolerability of BIIB023 in Chinese, Japanese, and Caucasian Healthy Volunteers (clinicaltrials.gov) - Mar 14, 2012
P1, N=48, Completed, Sponsor: Biogen Idec
Initiation date: Jan 2012 --> Jul 2012 Active, not recruiting --> Completed
- |||| BIIB023 / Biogen
Enrollment open: ATLAS: BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis (clinicaltrials.gov) - Feb 15, 2012
P2, N=300, Recruiting, Sponsor: Biogen Idec
Active, not recruiting --> Completed Not yet recruiting --> Recruiting
- ||||| BIIB023 / Biogen
New P2 trial: ATLAS: BIIB023 Proof-of-Concept Study in Participants With Lupus Nephritis (clinicaltrials.gov) - Dec 22, 2011
P2, N=300, Recruiting, Sponsor: Biogen Idec